Speaker Profile

Ph.D, SVP of Global Strategy, T-Cure Bioscience, Inc.
Biography

Dr. Ying has over 25 years pharmaceutical experience in oncology drug R&D, regulatory submission, clinical studies, and in starting and building biotech start-ups. He received his PhD at Stanford University in Cancer Biology Program, completed his post doctoral training with Drs. Nicholas Restifo and Steven Rosenberg at the US National Cancer Institute. He became a principal investigator at Maxine Dunitz Neurosurgical Institute (affiliated with UCLA), where he oversaw a clinical laboratory conducting Dendritic Cell Vaccine trials for malignant brain tumor. He joined Berlex Biosciences (R&D arm of Schering A.G.) as a project leader in cancer research department, then joined Monogram Biosciences, a personalized medicine company that developed biomarkers for selection of patients for novel targeted drugs. In 2010, Dr. Ying co-founded Immunnova, a biotech company focused on dendritic cell vaccines and antigen-specific T cells. He was awarded grand champion in a national entrepreneurs contest in Jiangsu. He has consulted for several early or late-stage biotech companies in the field of cancer immunotherapy, including HRYZ (Dendritic cell vaccines), Sanpower Group/Dendreon and SinoBioway. He was the key technical expert in an international M&A team that completed the acquisition of Dendreon by Sanpower group (0.9 billion dollars), acquisition of China Life Science in Hong Kong. Currently he is SVP of global strategy at T-Cure Bioscience. He received Advanced Certificate in Regulatory Affairs USFDA in 2007.

Immunotherapy Showcase: T-Cure Bioscience, Inc.
T-Cure was established by a scientific team who were trained in Dr. Steven Rosenberg’s laboratory at US National Cancer Institute. Our focus is on isolating with our proprietary iSORT platform high avidity T-Cell Receptors (TCR) that can be used to engineer a patient’s T-Cells to recognize and kill cancer. Our lead TCR-T product 800TCR-T is currently in a phase I study lead by Dr. Childs at NCI. We are pleased to announce current openings for director/associate director and Scientists on our research and development team.

Don't Miss Important Precision Medicine Updates

PMWC is the most comprehensive precision medicine conference. To receive the lastest news and updates from the field, subscribe to the newsletter here.

Here is your coupon code: newsletter-5percentoff-THISWEEKONLY